Lung cancer signatures in plasma based on proteome profiling of mouse tumor models.

[1]  Jacob J. Kennedy,et al.  Tumor microenvironment-derived proteins dominate the plasma proteome response during breast cancer induction and progression. , 2011, Cancer research.

[2]  Jacob Kennedy,et al.  Plasma Proteome Profiles Associated with Inflammation, Angiogenesis, and Cancer , 2011, PloS one.

[3]  Gerald C. Chu,et al.  SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression , 2011, Nature.

[4]  W. Berger,et al.  Dual inhibition of EGFR and mTOR pathways in small cell lung cancer , 2010, British Journal of Cancer.

[5]  A. Sweet-Cordero,et al.  Loss of p130 accelerates tumor development in a mouse model for human small-cell lung carcinoma. , 2010, Cancer research.

[6]  P. Rouanet,et al.  Serum protein signature may improve detection of ductal carcinoma in situ of the breast , 2010, Oncogene.

[7]  Liese C C Pruitt,et al.  Integrated Proteomic Analysis of Human Cancer Cells and Plasma from Tumor Bearing Mice for Ovarian Cancer Biomarker Discovery , 2009, PloS one.

[8]  D. Feldser,et al.  Requirement for NF-κB signalling in a mouse model of lung adenocarcinoma , 2009, Nature.

[9]  S. Richard,et al.  Identification of a Sam68 Ribonucleoprotein Complex Regulated by Epidermal Growth Factor* , 2009, The Journal of Biological Chemistry.

[10]  L. Hood,et al.  Deep depletion of abundant serum proteins reveals low‐abundant proteins as potential biomarkers for human ovarian cancer , 2009, Proteomics. Clinical applications.

[11]  R. Lewensohn,et al.  Use of narrow‐range peptide IEF to improve detection of lung adenocarcinoma markers in plasma and pleural effusion , 2009, Proteomics.

[12]  S. Lam,et al.  Connective tissue-activating peptide III: a novel blood biomarker for early lung cancer detection. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Caicun Zhou,et al.  Clinicopathological features and epidermal growth factor receptor mutations associated with epithelial–mesenchymal transition in non‐small cell lung cancer , 2009, Respirology.

[14]  Claude C. Warzecha,et al.  ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing. , 2009, Molecular cell.

[15]  S. Hanash,et al.  Comprehensive Proteome Analysis of an Apc Mouse Model Uncovers Proteins Associated with Intestinal Tumorigenesis , 2009, Cancer Prevention Research.

[16]  S. Hanash,et al.  In-depth proteomics to define the cell surface and secretome of ovarian cancer cells and processes of protein shedding. , 2009, Cancer research.

[17]  S. Hanash,et al.  Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  J. Pérez-Gil,et al.  Structure of pulmonary surfactant membranes and films: the role of proteins and lipid-protein interactions. , 2008, Biochimica et biophysica acta.

[19]  S. Hanash,et al.  Proteomic Analysis of Ovarian Cancer Cells Reveals Dynamic Processes of Protein Secretion and Shedding of Extra-Cellular Domains , 2008, PloS one.

[20]  Michelle A. Anderson,et al.  A Mouse to Human Search for Plasma Proteome Changes Associated with Pancreatic Tumor Development , 2008, PLoS medicine.

[21]  S. Hanash,et al.  Plasma proteome profiling of a mouse model of breast cancer identifies a set of up-regulated proteins in common with human breast cancer cells. , 2008, Journal of proteome research.

[22]  Derek Y. Chiang,et al.  Characterizing the cancer genome in lung adenocarcinoma , 2007, Nature.

[23]  W. Gerald,et al.  Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. , 2007, The Journal of clinical investigation.

[24]  Veronika A. Glukhova,et al.  Contribution of protein fractionation to depth of analysis of the serum and plasma proteomes. , 2007, Journal of proteome research.

[25]  Y. Yatabe,et al.  Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1. , 2007, Cancer research.

[26]  M. Páez de la Cadena,et al.  Alteration of the serum levels of the epidermal growth factor receptor and its ligands in patients with non-small cell lung cancer and head and neck carcinoma , 2007, British Journal of Cancer.

[27]  M. Mann,et al.  A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC) , 2006, Nature Protocols.

[28]  J. Crowley,et al.  Bortezomib (PS-341) in Relapsed or Refractory Extensive Stage Small Cell Lung Cancer: A Southwest Oncology Group Phase II Trial (S0327) , 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[29]  Brendan MacLean,et al.  General framework for developing and evaluating database scoring algorithms using the TANDEM search engine , 2006, Bioinform..

[30]  Veronika A. Glukhova,et al.  Quantitative analysis of acrylamide labeled serum proteins by LC-MS/MS. , 2006, Journal of proteome research.

[31]  H. Varmus,et al.  Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors. , 2006, Genes & development.

[32]  H. Frierson,et al.  Comprehensive analysis of HE4 expression in normal and malignant human tissues , 2006, Modern Pathology.

[33]  Ewa Wójcik,et al.  Pretreatment Serum Levels of Cytokines and Cytokine Receptors in Patients with Non-Small Cell Lung Cancer, and Correlations with Clinicopathological Features and Prognosis , 2006, Oncology.

[34]  S. Cross,et al.  WFDC2 (HE4): A potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung , 2006, Respiratory research.

[35]  Jeffrey T. Chang,et al.  Oncogenic pathway signatures in human cancers as a guide to targeted therapies , 2006, Nature.

[36]  B. de Strooper,et al.  ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[37]  G. Omenn,et al.  The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements. , 2004, Journal of the National Cancer Institute.

[38]  G. Millat,et al.  Structure and function of the NPC2 protein. , 2004, Biochimica et biophysica acta.

[39]  E. Birney,et al.  The International Protein Index: An integrated database for proteomics experiments , 2004, Proteomics.

[40]  Robertson Craig,et al.  TANDEM: matching proteins with tandem mass spectra. , 2004, Bioinformatics.

[41]  J. Yates,et al.  A model for random sampling and estimation of relative protein abundance in shotgun proteomics. , 2004, Analytical chemistry.

[42]  T. Yanagida,et al.  Engagement of CD44 Promotes Rac Activation and CD44 Cleavage during Tumor Cell Migration* , 2004, Journal of Biological Chemistry.

[43]  H. Samaratunga,et al.  Expression of the Disintegrin Metalloprotease, ADAM-10, in Prostate Cancer and Its Regulation by Dihydrotestosterone, Insulin-Like Growth Factor I, and Epidermal Growth Factor in the Prostate Cancer Cell Model LNCaP , 2004, Clinical Cancer Research.

[44]  A. Berns,et al.  Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. , 2003, Cancer cell.

[45]  R. Aebersold,et al.  A statistical model for identifying proteins by tandem mass spectrometry. , 2003, Analytical chemistry.

[46]  S. Duan,et al.  Induction of tumor angiogenesis by Slit-Robo signaling and inhibition of cancer growth by blocking Robo activity. , 2003, Cancer cell.

[47]  Michèl Schummer,et al.  The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. , 2003, Cancer research.

[48]  Rolf Apweiler,et al.  Faculty Opinions recommendation of Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. , 2003 .

[49]  Mitchell D Schnall,et al.  Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis. , 2002, Cancer cell.

[50]  Alexey I Nesvizhskii,et al.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. , 2002, Analytical chemistry.

[51]  Z. Werb,et al.  The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein–coupled receptors , 2002, The Journal of cell biology.

[52]  G. Camenisch,et al.  ANGPTL3 Stimulates Endothelial Cell Adhesion and Migration via Integrin αvβ3 and Induces Blood Vessel Formation in Vivo * , 2002, The Journal of Biological Chemistry.

[53]  T. Fujiwara,et al.  Angptl3 regulates lipid metabolism in mice , 2002, Nature Genetics.

[54]  H. Varmus,et al.  Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. , 2001, Genes & development.

[55]  T. Rabbitts,et al.  Inadequate lung development and bronchial hyperplasia in mice with a targeted deletion in the Dutt1/Robo1 gene , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[56]  P. Herrlich,et al.  Regulation of alternative pre‐mRNA splicing by the ERK MAP‐kinase pathway , 2001, The EMBO journal.

[57]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[58]  S. Infusino,et al.  Serum concentrations of proinflammatory cytokines in advanced non small cell lung cancer patients. , 1998, Journal of experimental & clinical cancer research : CR.

[59]  J. Roth,et al.  Ki‐ras and p53 mutations are early and late events, respectively, in urethane‐induced pulmonary carcinogenesis in A/J mice , 1996, Molecular carcinogenesis.

[60]  J. Ben-Ezra,et al.  Small cell carcinomas of the lung express the Bcl-2 protein. , 1994, The American journal of pathology.

[61]  Charles Darwin,et al.  Experiments , 1800, The Medical and physical journal.

[62]  Rob J. van Klaveren,et al.  Screening and Early Detection of Lung Cancer , 2011, Cancer journal.

[63]  Adam Rauch,et al.  Computational Proteomics Analysis System (CPAS): an extensible, open-source analytic system for evaluating and publishing proteomic data and high throughput biological experiments. , 2006, Journal of proteome research.

[64]  T. Jacks,et al.  Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer , 2005, Nature Medicine.

[65]  P. Herrlich,et al.  CD44: From adhesion molecules to signalling regulators , 2003, Nature Reviews Molecular Cell Biology.

[66]  G. Pelosi,et al.  Detection of the neural cell adhesion molecule (NCAM) in serum of patients with small‐cell lung cancer (SCLC) with “limited” or “extensive” disease, and bone‐marrow infiltration , 1994, International journal of cancer. Supplement = Journal international du cancer. Supplement.

[67]  A. Vangsted,et al.  New serum markers for small-cell lung cancer. II. The neural cell adhesion molecule, NCAM. , 1994, Cancer detection and prevention.